| Year |
Citation |
Score |
| 2020 |
Dubaisi S, Fang H, Caruso JA, Gaedigk R, Vyhlidal CA, Kocarek TA, Runge-Morris M. Developmental Expression of SULT1C4 Transcript Variants in Human Liver: Implications for Discordance Between SULT1C4 mRNA and Protein Levels. Drug Metabolism and Disposition: the Biological Fate of Chemicals. PMID 32303576 DOI: 10.1124/Dmd.120.090829 |
0.48 |
|
| 2019 |
Dubaisi S, Caruso JA, Gaedigk R, Vyhlidal CA, Smith PC, Hines RN, Kocarek TA, Runge-Morris M. Developmental Expression of the Cytosolic Sulfotransferases in Human Liver. Drug Metabolism and Disposition: the Biological Fate of Chemicals. PMID 30885913 DOI: 10.1124/Dmd.119.086363 |
0.457 |
|
| 2018 |
Dubaisi S, Barrett KG, Fang H, Guzman-Lepe J, Soto-Gutierrez A, Kocarek TA, Runge-Morris M. Regulation of Cytosolic Sulfotransferases in Models of Human Hepatocyte Development. Drug Metabolism and Disposition: the Biological Fate of Chemicals. PMID 29858374 DOI: 10.1124/Dmd.118.081398 |
0.578 |
|
| 2017 |
Guidry AL, Tibbs ZE, Runge-Morris M, Falany CN. Expression, purification and characterization of human cytosolic sulfotransferase (SULT) 1C4. Hormone Molecular Biology and Clinical Investigation. 29: 27-36. PMID 28222028 DOI: 10.1515/Hmbci-2016-0053 |
0.387 |
|
| 2016 |
Dubaisi S, Fang H, Kocarek TA, Runge-Morris M. Transcriptional Regulation of Human Cytosolic Sulfotransferase 1C3 by Peroxisome Proliferator-Activated Receptor γ in LS180 Human Colorectal Adenocarcinoma Cells. Molecular Pharmacology. PMID 27565680 DOI: 10.1124/Mol.116.106005 |
0.477 |
|
| 2016 |
Barrett KG, Fang H, Kocarek TA, Runge-Morris M. Transcriptional Regulation of SULT1C2 by Vitamin D Receptor in LS180 Human Colorectal Adenocarcinoma Cells. Drug Metabolism and Disposition: the Biological Fate of Chemicals. PMID 27130351 DOI: 10.1124/Dmd.116.070300 |
0.476 |
|
| 2015 |
Barrett KG, Fang H, Cukovic D, Dombkowski AA, Kocarek TA, Runge-Morris M. Upregulation of UGT2B4 Expression by 3'-Phosphoadenosine-5'-Phosphosulfate Synthase Knockdown: Implications for Coordinated Control of Bile Acid Conjugation. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 43: 1061-70. PMID 25948711 DOI: 10.1124/Dmd.114.061440 |
0.538 |
|
| 2014 |
Rondini EA, Fang H, Runge-Morris M, Kocarek TA. Regulation of human cytosolic sulfotransferases 1C2 and 1C3 by nuclear signaling pathways in LS180 colorectal adenocarcinoma cells. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 42: 361-8. PMID 24335393 DOI: 10.1124/Dmd.113.055673 |
0.529 |
|
| 2014 |
Duniec-Dmuchowski Z, Rondini EA, Tibbs ZE, Falany CN, Runge-Morris M, Kocarek TA. Expression of the orphan cytosolic sulfotransferase SULT1C3 in human intestine: characterization of the transcript variant and implications for function. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 42: 352-60. PMID 24335392 DOI: 10.1124/Dmd.113.055665 |
0.374 |
|
| 2013 |
Runge-Morris M, Kocarek TA. Expression of the sulfotransferase 1C family: implications for xenobiotic toxicity. Drug Metabolism Reviews. 45: 450-9. PMID 24028175 DOI: 10.3109/03602532.2013.835634 |
0.428 |
|
| 2013 |
Barrett KG, Fang H, Gargano MD, Markovich D, Kocarek TA, Runge-Morris M. Regulation of murine hepatic hydroxysteroid sulfotransferase expression in hyposulfatemic mice and in a cell model of 3'-phosphoadenosine-5'-phosphosulfate deficiency. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 41: 1505-13. PMID 23674610 DOI: 10.1124/Dmd.113.051912 |
0.53 |
|
| 2013 |
Runge-Morris M, Kocarek TA, Falany CN. Regulation of the cytosolic sulfotransferases by nuclear receptors. Drug Metabolism Reviews. 45: 15-33. PMID 23330539 DOI: 10.3109/03602532.2012.748794 |
0.417 |
|
| 2011 |
Salman ED, He D, Runge-Morris M, Kocarek TA, Falany CN. Site-directed mutagenesis of human cytosolic sulfotransferase (SULT) 2B1b to phospho-mimetic Ser348Asp results in an isoform with increased catalytic activity Journal of Steroid Biochemistry and Molecular Biology. 127: 315-323. PMID 21855633 DOI: 10.1016/J.Jsbmb.2011.07.010 |
0.331 |
|
| 2011 |
Fu J, Fang H, Paulsen M, Ljungman M, Kocarek TA, Runge-Morris M. Regulation of estrogen sulfotransferase expression by confluence of MCF10A breast epithelial cells: role of the aryl hydrocarbon receptor. The Journal of Pharmacology and Experimental Therapeutics. 339: 597-606. PMID 21828262 DOI: 10.1124/Jpet.111.185173 |
0.666 |
|
| 2011 |
Bai Q, Xu L, Kakiyama G, Runge-Morris MA, Hylemon PB, Yin L, Pandak WM, Ren S. Sulfation of 25-hydroxycholesterol by SULT2B1b decreases cellular lipids via the LXR/SREBP-1c signaling pathway in human aortic endothelial cells. Atherosclerosis. 214: 350-6. PMID 21146170 DOI: 10.1016/J.Atherosclerosis.2010.11.021 |
0.346 |
|
| 2010 |
Fu J, Weise AM, Falany JL, Falany CN, Thibodeau BJ, Miller FR, Kocarek TA, Runge-Morris M. Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression. Breast Cancer Research and Treatment. 120: 35-45. PMID 19308726 DOI: 10.1007/S10549-009-0363-8 |
0.619 |
|
| 2009 |
Runge-Morris M, Kocarek TA. Regulation of sulfotransferase and UDP-glucuronosyltransferase gene expression by the PPARs. Ppar Research. 2009: 728941. PMID 19680455 DOI: 10.1155/2009/728941 |
0.388 |
|
| 2009 |
Cook IT, Duniec-Dmuchowski Z, Kocarek TA, Runge-Morris M, Falany CN. 24-hydroxycholesterol sulfation by human cytosolic sulfotransferases: formation of monosulfates and disulfates, molecular modeling, sulfatase sensitivity, and inhibition of liver x receptor activation. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 37: 2069-78. PMID 19589875 DOI: 10.1124/Dmd.108.025759 |
0.399 |
|
| 2009 |
Falany CN, He D, Li L, Falany JL, Wilborn TW, Kocarek TA, Runge-Morris M. Regulation of hepatic sulfotransferase (SULT) 1E1 expression and effects on estrogenic activity in cystic fibrosis (CF). The Journal of Steroid Biochemistry and Molecular Biology. 114: 113-9. PMID 19429440 DOI: 10.1016/J.Jsbmb.2009.02.009 |
0.504 |
|
| 2009 |
Duniec-Dmuchowski Z, Fang HL, Strom SC, Ellis E, Runge-Morris M, Kocarek TA. Human pregnane X receptor activation and CYP3A4/CYP2B6 induction by 2,3-oxidosqualene:lanosterol cyclase inhibition. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 37: 900-8. PMID 19158313 DOI: 10.1124/Dmd.108.025130 |
0.467 |
|
| 2008 |
Kocarek TA, Duanmu Z, Fang HL, Runge-Morris M. Age- and sex-dependent expression of multiple murine hepatic hydroxysteroid sulfotransferase (SULT2A) genes. Biochemical Pharmacology. 76: 1036-46. PMID 18725207 DOI: 10.1016/J.Bcp.2008.07.032 |
0.439 |
|
| 2007 |
Fang HL, Strom SC, Ellis E, Duanmu Z, Fu J, Duniec-Dmuchowski Z, Falany CN, Falany JL, Kocarek TA, Runge-Morris M. Positive and negative regulation of human hepatic hydroxysteroid sulfotransferase (SULT2A1) gene transcription by rifampicin: roles of hepatocyte nuclear factor 4alpha and pregnane X receptor. The Journal of Pharmacology and Experimental Therapeutics. 323: 586-98. PMID 17687072 DOI: 10.1124/Jpet.107.124610 |
0.675 |
|
| 2006 |
Thomas RD, Green MR, Wilson C, Weckle AL, Duanmu Z, Kocarek TA, Runge-Morris M. Cytochrome P450 expression and metabolic activation of cooked food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in MCF10A breast epithelial cells. Chemico-Biological Interactions. 160: 204-16. PMID 16527260 DOI: 10.1016/J.Cbi.2006.01.007 |
0.461 |
|
| 2006 |
Duanmu Z, Weckle A, Koukouritaki SB, Hines RN, Falany JL, Falany CN, Kocarek TA, Runge-Morris M. Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre- and postnatal human liver. The Journal of Pharmacology and Experimental Therapeutics. 316: 1310-7. PMID 16339912 DOI: 10.1124/Jpet.105.093633 |
0.468 |
|
| 2005 |
Fang HL, Strom SC, Cai H, Falany CN, Kocarek TA, Runge-Morris M. Regulation of human hepatic hydroxysteroid sulfotransferase gene expression by the peroxisome proliferator-activated receptor alpha transcription factor. Molecular Pharmacology. 67: 1257-67. PMID 15635043 DOI: 10.1124/Mol.104.005389 |
0.532 |
|
| 2005 |
Fang HL, Abdolalipour M, Duanmu Z, Smigelski JR, Weckle A, Kocarek TA, Runge-Morris M. Regulation of glucocorticoid-inducible hydroxysteroid sulfotransferase (SULT2A-40/41) gene transcription in primary cultured rat hepatocytes: role of CCAAT/enhancer-binding protein liver-enriched transcription factors. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 33: 147-56. PMID 15502011 DOI: 10.1124/Dmd.104.000281 |
0.499 |
|
| 2004 |
Shenoy SD, Spencer TA, Mercer-Haines NA, Abdolalipour M, Wurster WL, Runge-Morris M, Kocarek TA. Induction of CYP3A by 2,3-oxidosqualene:lanosterol cyclase inhibitors is mediated by an endogenous squalene metabolite in primary cultured rat hepatocytes. Molecular Pharmacology. 65: 1302-12. PMID 15102959 DOI: 10.1124/Mol.65.5.1302 |
0.44 |
|
| 2004 |
Shenoy SD, Spencer TA, Mercer-Haines NA, Alipour M, Gargano MD, Runge-Morris M, Kocarek TA. CYP3A induction by liver x receptor ligands in primary cultured rat and mouse hepatocytes is mediated by the pregnane X receptor. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 32: 66-71. PMID 14709622 DOI: 10.1124/Dmd.32.1.66 |
0.477 |
|
| 2003 |
Fang HL, Shenoy S, Duanmu Z, Kocarek TA, Runge-Morris M. Transactivation of glucocorticoid-inducible rat aryl sulfotransferase (SULT1A1) gene transcription. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 31: 1378-81. PMID 14570770 DOI: 10.1124/Dmd.31.11.1378 |
0.479 |
|
| 2002 |
Kocarek TA, Shenoy SD, Mercer-Haines NA, Runge-Morris M. Use of dominant negative nuclear receptors to study xenobiotic-inducible gene expression in primary cultured hepatocytes. Journal of Pharmacological and Toxicological Methods. 47: 177-87. PMID 12628309 DOI: 10.1016/S1056-8719(03)00002-9 |
0.475 |
|
| 2002 |
Duanmu Z, Locke D, Smigelski J, Wu W, Dahn MS, Falany CN, Kocarek TA, Runge-Morris M. Effects of dexamethasone on aryl (SULT1A1)- and hydroxysteroid (SULT2A1)-sulfotransferase gene expression in primary cultured human hepatocytes. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 30: 997-1004. PMID 12167565 DOI: 10.1124/Dmd.30.9.997 |
0.421 |
|
| 2001 |
Wu W, Kocarek TA, Runge-Morris M. Sex-dependent regulation by dexamethasone of murine hydroxysteroid sulfotransferase gene expression. Toxicology Letters. 119: 235-246. PMID 11246177 DOI: 10.1016/S0378-4274(01)00263-6 |
0.477 |
|
| 2000 |
Duanmu Z, Dunbar J, Falany CN, Runge-Morris M. Induction of rat hepatic aryl sulfotransferase (SULT1A1) gene expression by triamcinolone acetonide: impact on minoxidil-mediated hypotension. Toxicology and Applied Pharmacology. 164: 312-320. PMID 10799342 DOI: 10.1006/Taap.2000.8911 |
0.427 |
|
| 1999 |
Runge-Morris M, Wu W, Kocarek TA. Regulation of rat hepatic hydroxysteroid sulfotransferase (SULT2-40/41) gene expression by glucocorticoids: evidence for a dual mechanism of transcriptional control. Molecular Pharmacology. 56: 1198-1206. PMID 10570047 DOI: 10.1124/Mol.56.6.1198 |
0.479 |
|
| 1998 |
Runge-Morris M. Regulation of sulfotransferase gene expression by glucocorticoid hormones and xenobiotics in primary rat hepatocyte culture Chemico-Biological Interactions. 109: 315-327. PMID 9566755 DOI: 10.1016/S0009-2797(97)00142-7 |
0.539 |
|
| 1997 |
Runge-Morris MA. Regulation of expression of the rodent cytosolic sulfotransferases. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 11: 109-17. PMID 9039952 |
0.399 |
|
| 1994 |
Runge-Morris MA. Sulfotransferase gene expression in rat hepatic and extrahepatic tissues. Chemico-Biological Interactions. 92: 67-76. PMID 8033271 DOI: 10.1016/0009-2797(94)90054-X |
0.47 |
|
| 1993 |
States JC, Quan T, Hines RN, Novak RF, Runge-Morris M. Expression of human cytochrome P450 1A1 in DNA repair deficient and proficient human fibroblasts stably transformed with an inducible expression vector. Carcinogenesis. 14: 1643-9. PMID 8353849 DOI: 10.1093/Carcin/14.8.1643 |
0.382 |
|
| 1991 |
Runge-Morris M, Wilusz J. Age and gender-related gene expression of hydroxysteroid sulfotransferase-a in rat liver Biochemical and Biophysical Research Communications. 175: 1051-1056. PMID 1709009 DOI: 10.1016/0006-291X(91)91671-X |
0.342 |
|
| Show low-probability matches. |